Edition:
United Kingdom

Morepen Laboratories Ltd (MORL.NS)

MORL.NS on National Stock Exchange of India

25.85INR
21 Sep 2018
Change (% chg)

Rs-0.95 (-3.54%)
Prev Close
Rs26.80
Open
Rs27.45
Day's High
Rs27.75
Day's Low
Rs25.50
Volume
887,047
Avg. Vol
1,362,387
52-wk High
Rs44.45
52-wk Low
Rs15.70

Latest Key Developments (Source: Significant Developments)

Morepen Laboratories Gets Shareholders' Nod For Re-Appointment Of Sushil Suri As Chairman And MD
Friday, 21 Sep 2018 

Sept 21 (Reuters) - Morepen Laboratories Ltd ::GETS SHAREHOLDERS' NOD FOR RE-APPOINTMENT OF SUSHIL SURI AS CHAIRMAN AND MD.  Full Article

India's Morepen Laboratories June Quarter Net Profit Rises
Monday, 13 Aug 2018 

Aug 13 (Reuters) - Morepen Laboratories Ltd ::JUNE QUARTER CONSOL NET PROFIT 24.6 MILLION RUPEES VERSUS PROFIT OF 12.7 MILLION RUPEES YEAR AGO.JUNE QUARTER CONSOL REVENUE FROM OPERATIONS 1.64 BILLION RUPEES VERSUS 1.31 BILLION RUPEES YEAR AGO.  Full Article

India's Morepen Laboratories March-Qtr Net Profit Falls
Wednesday, 16 May 2018 

May 16 (Reuters) - Morepen Laboratories Ltd ::MARCH QUARTER NET PROFIT 41.1 MILLION RUPEES VERSUS PROFIT 71.5 MILLION RUPEES YEAR AGO.MARCH QUARTER REVENUE FROM OPERATIONS 1.58 BILLION RUPEES VERSUS 1.45 BILLION RUPEES YEAR AGO.  Full Article

India's Morepen Laboratories Gets U.S. FDA Nod For Bulk Drug Montelukast Sodium
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Morepen Laboratories Ltd ::GETS U.S. FDA CLEARANCE FOR ITS BULK DRUG MONTELUKAST SODIUM.  Full Article

India's Morepen Labs Sept-qtr profit rises
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Morepen Laboratories Ltd ::Sept quarter net profit 103.8 million rupees versus 83.4 million rupees year ago.Sept quarter revenue from operations 1.38 billion rupees versus 1.43 billion rupees year ago.  Full Article